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Abstract
Background: The aim of this study was to examine the relationship between chronic neuropathic pain after 
incomplete peripheral nerve lesion, chronic nociceptive pain due to osteoarthritis, and the excitability of the motor 
cortex assessed by transcranial magnetic stimulation (TMS). Hence in 26 patients with neuropathic pain resulting from 
an isolated incomplete lesion of the median or ulnar nerve (neuralgia), 20 patients with painful osteoarthritis of the 
hand, and 14 healthy control subjects, the excitability of the motor cortex was tested using paired-pulse TMS to assess 
intracortical inhibition and facilitation. These excitability parameters were compared between groups, and the 
relationship between excitability parameters and clinical parameters was examined.
Results: We found a significant reduction of intracortical inhibition in the hemisphere contralateral to the lesioned 
nerve in the neuralgia patients. Intracortical inhibition in the ipsilateral hemisphere of neuralgia patients and in both 
hemispheres of osteoarthritis patients did not significantly differ from the control group. Disinhibition was significantly 
more pronounced in neuralgia patients with moderate/severe pain intensity than in patients with mild pain intensity, 
whereas the relative compound motor action potential as a parameter of nerve injury severity did not correlate with 
the amount of disinhibition.
Conclusions: Our results suggest a close relationship between motor cortex inhibition and chronic neuropathic pain 
in the neuralgia patients, which is independent from nerve injury severity. The lack of cortical disinhibition in patients 
with painful osteoarthritis points at differences in the pathophysiological processes of different chronic pain conditions 
with respect to the involvement of different brain circuitry.
Background
Lesions of a motor or mixed peripheral nerve lead to
short- and long-term reorganization of the motor cortex,
as demonstrated in a large number of animal studies [1-
3]. Similar motor cortex reorganization was shown to
result from limb amputation in humans [4,5]. This motor
cortex reorganization in amputees was linked to the
occurrence and intensity of phantom limb pain [6], but
was also observed in amputees without pain [7], as well as
in patients with other chronic neuropathic pain condi-
tions [8,9]. The exact relationship between peripheral
deafferentation, neuropathic pain and motor cortex reor-
ganization therefore remains still debatable. At least in its
early phase, motor cortex reorganization is mainly based
on functional changes of synaptic efficacy, involving the
removal of local GABAergic inhibition [10], and long-
term potentiation-like mechanisms [11]. These func-
tional synaptic changes are thought to be reflected by
changes in intracortical inhibition (ICI) and facilitation
(ICF) assessed by paired-pulse transcranial magnetic
stimulation (TMS), as previously demonstrated in limb
amputees, who showed a reduced ICI and an enhanced
ICF in the hemisphere contralateral to the amputation
[12,13]. In patients with different chronic neuropathic
pain syndromes of central and peripheral origin, ICI in
the motor cortex was found to be reduced, whereas resto-
ration of ICI by repetitive transcranial magnetic stimula-
tion (rTMS) applied to the motor cortex was paralleled by
a reduction in pain intensity, suggesting a close relation-
ship between ICI and chronic neuropathic pain [14]. Sim-
ilarly, patients with complex regional pain syndrome
(CRPS) showed a reduced ICI, which was more pro-
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nounced in patients with higher pain intensity [15]. In
these patients ICI was reduced not only in the contralat-
eral, but also in the ipsilateral motor cortex, which points
at differences in the underlying pathophysiological pro-
cesses.
In the present study, we assessed ICI and ICF by paired-
pulse TMS in patients with chronic neuropathic pain due
to an incomplete peripheral nerve lesion, and with
chronic nociceptive pain due to osteoarthritis. Our aim
was to examine the relationship between chronic neuro-
pathic pain of peripheral origin and cortical excitability
changes in the motor cortex, and to assess possible differ-
ences between chronic neuropathic and nociceptive pain
conditions.
Results
Group characteristics
There was no significant difference between the neuralgia
group, the osteoarthritis group and the healthy controls
with respect to the patients' age (F2,57 = 2.612, p = 0.082).
Neuralgia patients did not significantly differ from
osteoarthritis patients with respect to current (p = 0.173)
and mean (p = 0.700) pain intensity, whereas maximum
pain intensity was significantly higher in the osteoarthri-
tis patients (p = 0.032; Cohen's d = 0.73). Duration of pain
did not significantly differ between both groups (p =
0.788).
Intracortical inhibition (ICI)
Comparing ICI between the three groups, and looking at
the recordings taken from the muscle supplied by the
lesioned nerve in the neuralgia group (abductor pollicis
brevis, APB, in median nerve lesions; adductor digiti
minimi, ADM, in ulnar nerve lesions), there was a signifi-
cant "group" effect (F2,57 = 10.433, p < 0.001), and a signif-
icant interaction between "side" and "group" (F2,57 = 4.560,
p = 0.015), whereas the factor "side" did not reach signifi-
cance (F1,57 = 3.140, p = 0.082). Post hoc analysis revealed
a significantly reduced ICI at the neuralgia patients'
affected side (relative amplitude 69.1 ± 53.4%) as com-
pared to their unaffected side (relative amplitude 40.7 ±
26.4%, p = 0.010, Cohen's d = 0.67), whereas no signifi-
cant side-to-side differences were observed in the
osteoarthritis patients and the control group. ICI did not
significantly differ between the osteoarthritis group and
the control group. However, ICI was significantly reduced
at the neuralgia patients' affected side as compared to the
controls' left hand (relative amplitude 26.9 ± 13.0%, p =
0.001, Cohen's d = 1.09), whereas no significant difference
was seen between the neuralgia patients' unaffected side
and the controls' right hand (relative amplitude 27.8 ±
21.8%, p = 0.128) (Figure 1).
Including the results obtained from the muscle sup-
plied by the unlesioned nerve in the neuralgia group in
the statistical analysis (APB in ulnar nerve lesions; ADM
in median nerve lesions), similar results were obtained:
ANOVA also revealed a significant "group" effect (F2,51 =
8.949, p < 0.001), and a significant interaction between
"side" and "group" (F2,51 = 4.356, p = 0.018), whereas the
factor "side" did not reach significance (F1,51 = 3.387, p =
0.072). Again, post hoc testing revealed a significantly
reduced ICI at the neuralgia patients' affected side (71.0%
± 61.8%) in comparison to their unaffected side (37.2% ±
23.7%, p = 0.028, Cohen's d = 0.72), but also in compari-
son to the controls' left hand (p = 0.005, Cohen's d = 0.99),
whereas no significant difference was seen between the
neuralgia patients' unaffected side and the controls' right
hand (p = 0.253) (Figure 1).
Intracortical facilitation (ICF)
Including the neuralgia group results obtained from the
muscle supplied by the lesioned nerve in the statistical
analysis (APB in median nerve lesions, ADM in ulnar
nerve lesions), there was no significant effect of the factor
"side" (F1,57 = 1.846, p = 0.180) or the factor "group" (F2,57
= 1.203, p = 0.308), and also no significant interaction
between both factors (F2,57 = 1.038, p = 0.361). Similar
results were obtained when the values obtained from the
muscle supplied by the unlesioned nerve (APB in ulnar
nerve lesions, ADM in median nerve lesions) were
included in the analysis (F1,51 = 0.972, p = 0.329 for the
factor "side", F2,51 = 0.290, p = 0.750 for the factor "group",
F2,51 = 0.947, p = 0.395 for the interaction) (Figure 2).
MEP amplitudes after single test stimuli
In the paired pulse TMS-paradigm used in this study, the
intensity of the test stimulus (TS) was adjusted to evoke a
MEP of approximately 1 mV. Therefore, a side-to-side-
difference or a between-group-difference for the MEP
amplitudes after single test stimuli should be excluded.
This was confirmed by statistical testing including the
results from the muscle supplied by the lesioned nerve
(APB in median nerve lesions, ADM in ulnar nerve
lesions) (F1,57 = 1.433, p = 0.236 for the factor "side", F2,57
= 1.737, p = 0.185 for the factor "group", F2,57 = 0.649, p =
0.526 for the interaction) as well as from the muscle sup-
plied by the unlesioned nerve (APB in ulnar nerve
lesions, ADM in median nerve lesions) in the neuralgia
group (F1,51 = 1.487, p = 0.228 for the factor "side", F2,51 =
0.475, p = 0.625 for the factor "group", F2,51 = 0.068, p =
0.934 for the interaction).
Test stimulus intensity
Looking at the TS intensity relative to the motor thresh-
old (MT), and including the neuralgia group results
obtained from the muscle supplied by the lesioned nerve
(APB in median nerve lesions, ADM in ulnar nerveSchwenkreis et al. BMC Neuroscience 2010, 11:73
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lesions) in the statistical analysis, there was no significant
effect of the factor "side" (F1,57 = 1.102, p = 0.298) or the
factor "group" (F2,57 = 1.199, p = 0.309), and also no signif-
icant interaction between both factors (F2,57 = 0.709, p =
0.497). Relative TS intensity was 124.0 ± 5.5% of MT at
the affected and 123.6 ± 6.1% at the unaffected side in the
neuralgia patients, 121.1 ± 6.7% at the affected and 122.3
± 5.3% at the unaffected side in the osteoarthritis
patients, and 121.2 ± 5.2% at the left hand and 122.9 ±
5.8% at the right hand in the control group.
Including the results obtained from the muscle sup-
plied by the unlesioned nerve (APB in ulnar nerve
lesions, ADM in median nerve lesions) in the analysis for
the neuralgia group, no significant effect of the factor
"side" (F1,51 = 0.829, p = 0.367), "group" ((F2,51 = 0.720, p =
0.491) or the interaction between "side" and "group" (F2,51
= 0.534, p = 0.589) was detected either. Relative TS inten-
sity was 123.7 ± 7.1% of MT at the affected and 123.3 ±
5.8% at the unaffected side in the neuralgia patients.
Motor threshold
There was no significant effect of one of the factors, nei-
ther when the results from the muscle supplied by the
lesioned nerve (APB in median nerve lesions, ADM in
ulnar nerve lesions) were included in the analysis (F1,57 =
1.228, p = 0.272 for the factor "side", F2,57 = 1.313, p =
0.277 for the factor "group", F2,57 = 0.229, p = 0.796 for the
interaction), nor when the results from the muscle sup-
plied by the unlesioned nerve (APB in ulnar nerve
lesions, ADM in median nerve lesions) were included
(F1,51 = 1.991, p = 0.164 for the factor "side", F2,51 = 1.448,
p = 0.244 for the factor "group", F2,51 = 0.181, p = 0.835 for
the interaction). MT in the neuralgia group was 55.5 ±
10.2% at the affected and 55.0 ± 10.6% at the unaffected
side when recordings were drawn from a muscle supplied
by the lesioned nerve, and 56.0 ± 8.8% at the affected and
54.5 ± 9.4% at the unaffected side when recordings were
drawn from a muscle supplied by the unlesioned nerve.
In the osteoarthritis group, MT was 52.5 ± 9.7% at the
affected and 51.8 ± 10.0% at the unaffected side, and in
the control subjects 58.2 ± 9.7% at the left and 55.9 ± 9.4%
at the right hand.
In the neuralgia group, comparison between MT in the
muscle supplied by the lesioned and the muscle supplied
by the unlesioned nerve at the affected side did not reveal
a significant difference (p = 0.450).
Figure 1 Intracortical inhibition (ICI). Mean ICI (relative amplitude, expressed in %) in the neuralgia group, the osteoarthritis group and the control 
group. For the neuralgia group, results obtained from a muscle supplied by the lesioned nerve and results obtained from a muscle supplied by the 
unlesioned nerve are shown. Significant p values of post-hoc t-test are shown. Error bars indicate standard deviation.
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Relationship between ICI and clinical parameters in 
neuralgia patients
In order to further differentiate between the repercussion
of neuropathic pain and the repercussion of peripheral
nerve lesion on ICI, patients with peripheral nerve lesion
were divided into two separate groups according to their
current pain intensity as assessed by numeric rating scale
(NRS). Neuralgia patients with NRS≥4 were considered
to have moderate/severe pain, patients with NRS<4 to
have mild pain [16,17]. Two patients with poor German
language competence were excluded. When the record-
ings were drawn from a muscle supplied by the lesioned
nerve (APB in median nerve lesions, ADM in ulnar nerve
lesions), motor cortex disinhibition was significantly
more pronounced in the moderate/severe pain patients
(83.2% ± 60.8%) than in the mild pain patients (41.7% ±
18.9%, p = 0.019, Cohen's d = 0.92). Recordings from a
muscle supplied by the unlesioned nerve (APB in ulnar
nerve lesions, ADM in median nerve lesions) revealed a
similar tendency (83.6% ± 72.9% vs. 39.3% ± 20.3%),
which however failed to reach statistical significance (p =
0.063). Further subgroup analysis did not reveal a signifi-
cant difference in ICI between neuralgia patients with or
without hypesthesia, dysesthesia, mechanical allodynia or
muscle paresis. ICI did not differ between patients with
lesions of the median and ulnar nerve, neither when con-
s ide rin g t he  r ec or dings  fr om  a  m usc le  s upp lied by t he
lesioned nerve, nor by the unlesioned nerve.
There was no significant correlation between ICI and
the relative amplitude of the compound muscle action
potential (CMAP) after supramaximal electrical stimula-
tion of the lesioned nerve at the wrist (expressed as a per-
centage of the CMAP of the contralateral homologous
nerve), neither when the recordings were drawn from a
muscle supplied by the lesioned nerve (r=-0.271, p =
0.181), nor when the recordings were drawn from a mus-
cle supplied by the unlesioned nerve (r = 0.005, p =
0.984). There was no significant correlation between ICI
and the pain duration either.
Discussion
Our main finding was a significant reduction of ICI in the
motor cortex contralateral to the affected hand in neural-
gia patients, whereas painful osteoarthritis patients
showed no abnormalities of ICI with respect to an age-
matched control group.
In patients with entrapment of the median nerve at the
carpal tunnel, which constituted a subgroup of patients in
our study, it was previously shown that the chronic path-
ological modification of peripheral sensorimotor inputs
leads to an enhanced excitability and a reorganization of
the somatotopic map in the contralateral primary soma-
tosensory cortex (S1) [18-21]. Similar plastic changes
were shown to occur rapidly after a transient deafferenta-
tion induced by an anesthetic nerve bloc, being therefore
more likely based on functional synaptic mechanisms
Figure 2 Intracortical facilitation (ICF). Mean ICF (relative amplitude, expressed in %) in the neuralgia group, the osteoarthritis group and the con-
trol group. For the neuralgia group, results obtained from a muscle supplied by the lesioned nerve and results obtained from a muscle supplied by 
the unlesioned nerve are shown. Note that there are no significant differences between groups. Error bars indicate standard deviation.
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than on axonal sprouting and the formation of new syn-
apses [22,23]. The presence of similar changes in cortical
excitability and cortical map somatotopy in the primary
motor cortex (M1) of these patients has not been studied
so far. However, our results strongly suggest that the reor-
ganization previously observed in S1 is paralleled by sim-
ilar changes in M1 of patients with incomplete peripheral
nerve lesions.
Our results in neuralgia patients resemble the changes
of ICI observed in the contralateral motor cortex of
patients with upper or lower limb amputation [12,13].
Given the fact that motor cortex disinhibition is also
present in patients with limb amputation who do not suf-
fer from chronic pain [12], it might be argued that the
disinhibition is more closely related to the peripheral
nerve lesion rather than to the chronic neuropathic pain.
However, there are a number of arguments, which favor
the chronic neuropathic pain as the strongest determi-
nant of the reduced inhibition in our study: First, dividing
neuralgia patients into two subgroups according to their
current pain intensity revealed a significantly more pro-
nounced motor cortex disinhibition in the moderate/
s e v e r e  p a i n  ( N R S ≥ 4 )  a s  c o m p a r e d  t o  t h e  m i l d  p a i n
patients. Second, the relative CMAP amplitude as an
indicator of nerve injury severity did not correlate with
ICI. In addition, ICI did not significantly differ between
neuralgia patients with or without muscle paresis, indi-
cating that cortical disinhibition was also independent
from motor impairment. Third, there is evidence from
various studies in animal models that an altered cortical
excitation including reduction of GABA mediated inhibi-
tory transmission is a crucial pathophysiological mecha-
nism in chronic pain [24]. These excitability changes
mainly have been demonstrated for the anterior cingulate
cortex (ACC), but imaging studies revealed a close func-
tional relationship between ACC and M1 in chronic neu-
ropathic pain conditions [25,26]. Finally, in an
interventional study using rTMS to enhance ICI in M1 of
patients with chronic neuropathic pain of different cen-
tral or peripheral origin, increased intracortical inhibi-
tion was accompanied by reduced pain intensity,
emphasizing also the importance of the relationship
between motor cortex inhibition and chronic neuro-
pathic pain [14].
In our study, the reduced ICI was not restricted to
recordings drawn from a muscle supplied by the affected
nerve, but was also present when recordings were drawn
from a muscle supplied by an unaffected nerve, indicating
a more widespread lack of inhibition in the hand area of
the hemisphere contralateral to the lesioned nerve. This
finding points at reorganizational processes in areas adja-
cent to the cortical representation of the lesioned nerve.
It is in line with findings in patients with upper limb
amputation, who also exhibited reorganization in the cor-
tical representation of proximal stump muscles [7,27].
Besides, it offers a possible explanation for recent find-
ings in patients with chronic neuropathic pain, showing
that rTMS applied to a motor cortical area adjacent to the
representation of the painful zone is even more effective
in pain relief than rTMS applied to the motor cortical
area corresponding to the painful zone itself [28].
As a possible methodological problem, the MEP
responses recorded from the APB muscle might have
been contaminated by responses from ulnar muscles of
the thenar eminence, and therefore contain information
from muscles supplied by the lesioned as well as from
muscles supplied by the unlesioned nerve. However, since
ICI did not significantly differ between patients with
median and ulnar nerve lesions, this might not have
influenced our results.
In previous studies, it has been shown that the intensity
of the TS is critical for the assessment of ICI, and that dif-
ferences in TS intensities might confound ICI compari-
sons [29,30]. Especially, this would have been critical in
neuralgia patients, if the TS intensity required to achieve
a MEP of approximately 1 mV had been elevated due to
the peripheral nerve lesion. However, an elevated TS
intensity in the neuralgia group due to the peripheral
nerve lesion as a potential confounding factor was
excluded, since analysis of TS intensities relative to MT
revealed no significant difference within- or between-
groups. In addition, MT was similar in all groups, includ-
ing both the muscle supplied by the lesioned and the
muscle supplied by the unlesioned nerve in the neuralgia
group. Finally, the fact that a similar ICI reduction was
observed when recordings were drawn from the muscle
supplied by the unlesioned nerve at the neuralgia
patients' affected side strongly supports the assumption
that assessment of ICI was not confounded when record-
ings were drawn from the muscle supplied by the
lesioned nerve.
Motor cortex disinhibition was only seen in the neural-
gia group, whereas the osteoarthritis patients did not dif-
fer from the control group. In osteoarthritis, pain is
thought to arise as a consequence of physiological activa-
tion of primary nociceptive afferents by tissue-damaging
stimuli and processing of this activity within the nocicep-
tive system, whereas in chronic neuropathic pain such as
neuralgia, pain arises by activity generated within the
nociceptive system without physiological stimulation of
nociceptors [31]. This different activation of the nocicep-
tive system leads to differential plastic changes at the
level of primary sensory and dorsal horn neurons [32].
Although it is conceivable that this different activation of
the nociceptive system also leads to an involvement of
different brain circuitry in distinct pain conditions, the
extent of supraspinal reorganization and the factors driv-
ing the process are largely undiscovered [33]. A morpho-Schwenkreis et al. BMC Neuroscience 2010, 11:73
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metric imaging study revealed differences in prefrontal
and thalamic gray matter density as an indicator of differ-
ent CNS neuroplasticity between patients with neuro-
pathic and non-neuropathic chronic pain [34]. A number
of functional imaging studies using fMRI or PET showed
differences between neuropathic and nociceptive pain
conditions with respect to the activated brain regions
[33,35-38]. In addition, the pattern of intracortical inhibi-
tion in neuralgia patients did also differ from CRPS
patients, who previously were shown to have reduced
intracortial inhibition not only in the contralateral, but
also in the ipsilateral motor cortex, suggesting a more
widespread and bilateral reorganization of the motor sys-
tem in CRPS as compared to neuralgia [8,15,39]. In this
context, our present findings point at pathophysiological
differences between chronic neuropathic and chronic
nociceptive pain with respect to the involvement of cen-
tral motor circuitry.
The finding of a pain-related motor cortex disinhibition
in patients with chronic neuropathic, but not in chronic
nociceptive pain may have an impact on our understand-
ing of the therapeutical use of invasive or non-invasive
motor cortex stimulation in chronic pain conditions. The
restoration of defective ICI might be a crucial mechanism
to achieve pain relief in chronic neuropathic pain, as pre-
viously demonstrated by means of rTMS applied to the
m o t o r  c o rt e x  [ 1 4 ] .  I n t e r e s t i n g l y ,  i n  t h i s  p r evi o u s  s t u d y
only high-frequency rTMS led to an enhancement of ICI
in patients with chronic neuropathic pain, although high-
frequency rTMS generally is known to reduce ICI in
healthy subjects [40], supporting the view that rTMS
effects essentially depend on the state of cortical excit-
ability before stimulation [14]. On the other hand, the
lack of motor cortex disinhibition in patients with painful
osteoarthritis as a chronic non-neuropathic pain condi-
tion might allow predicting a therapy failure of rTMS
applied to the motor cortex in these patients.
Conclusions
Our results suggest a close relationship between motor
cortex inhibition and chronic neuropathic pain in the
neuralgia patients, which is independent from nerve
injury severity. The lack of cortical disinhibition in
patients with painful osteoarthritis points at differences
in the pathophysiological processes of different chronic
pain conditions with respect to the involvement of differ-
ent brain circuitry.
Methods
Subjects
We studied 26 patients (12 women, 14 men) with isolated
incomplete lesion of the median (n = 16) or ulnar (n = 10)
nerve as revealed by previous clinical and electroneuro-
graphical/electromyographical examination. In all
patients, the relative amplitude of the distal compound
muscle action potential (CMAP) after supramaximal
electrical stimulation of the lesioned nerve at the wrist
(expressed as a percentage of the CMAP of the contralat-
eral homologous nerve) was determined, and served as a
measure of nerve injury severity. All patients had a his-
tory of ongoing or intermittent neuropathic pain (neural-
gia) due to the peripheral nerve lesion. Peripheral nerve
lesion was due to trauma in 14 patients, due to entrap-
ment of the median nerve at the carpal tunnel in ten
patients, and due to entrapment of the ulnar nerve at the
elbow in two patients. Patients with concomitant neuro-
logical disorders were excluded. The patients' age was
between 24 and 77 years (mean 50.9 ± 11.7 years), and
duration of the neuralgia between 3 and 190 months
(mean 39.3 ± 44.8 months). The patients did not take any
central acting drugs when participating in the study.
Immediately before starting the TMS session, the current
pain intensity was assessed, and the patients were also
asked to retrospectively judge the mean and maximum
ongoing pain intensity during the week prior to the TMS
session using a numeric rating scale (NRS; values
between 0 = "no pain" to 10 = "maximal pain"). Clinical
details of the neuralgia patients are reported in Table 1.
In addition, 20 patients with unilateral painful primary
d e g e n e r a t i v e  o s t e o a r t h r i t i s  o f  t h e  h a n d  a s  a  m o d e l  o f
nociceptive, non-neuropathic pain (10 women, 10 men,
aged between 41 and 76 years, mean 56.6 ± 10.2 years)
were examined. A concomitant neurological disorder was
excluded by clinical examination performed by an experi-
enced neurologist (PS). Clinical details of the osteoarthri-
tis patients are also reported in Table 1.
Results obtained in the patients were compared with
results recorded from a control group of 14 right-handed
healthy volunteers (8 women, 6 men, aged between 35
and 79 years, mean 58.8 ± 12.7 years). All subjects partic-
ipating in the study gave their informed consent. The
study was approved by the ethical committee of the Ruhr-
University Bochum.
Transcranial magnetic stimulation
TMS was performed using a bistim module, which was
connected to two Magstim 200 stimulators (Magstim Co.,
Whitland, Dyfed, UK). The stimuli were applied through
a circular coil (outer diameter 14 cm) positioned over the
vertex with the current flowing anticlockwise in the coil
in order to activate predominantly the left hemisphere,
and clockwise in order to activate predominantly the
right hemisphere. Earlier studies had shown that focal
and circular coils elicited comparable results in paired-
pulse studies [41]. While stimulating the contralateral
hemisphere, recordings were taken with Ag-AgCl surface
electrodes from the abductor pollicis brevis (APB) and
from the abductor digiti minimi (ADM) muscle consecu-Schwenkreis et al. BMC Neuroscience 2010, 11:73
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Table 1: Clinical data of the neuralgia and painful osteoarthritis patients.
Neuralgia Painful osteoarthritis
N2 6 2 0
Sex (women/men) 12/14 10/10
Age (years; mean±SD) 50.9±11.7 56.6±10.2
Affected side (left/right) 16/10 6/14
Cause and site of nerve lesion
Carpal tunnel syndrome (median) 10 -
Traumatic, wrist (median) 6 -
Cubital tunnel syndrome (ulnar) 2 -
Traumatic, elbow (ulnar) 6 -
Traumatic, wrist (ulnar) 2 -
CMAP of the lesioned nerve (expressed as 
a percentage of the CMAP of the 
contralateral homologous nerve)
75.8±33.1 -
Duration of pain (months; mean±SD) 39.3±44.8 35.6±42.9
Pain intensity during previous week
Mean (NRS; mean±SD) 4.8±1.8 5.0±1.5
Maximal (NRS; mean±SD) 6.0±2.2 7.4±1.6
Current pain intensity (NRS; mean±SD) 4.7±2.1 3.9±2.0
Number of patients with
Hypesthesia 13 (50%) 0 (0%)
Dysesthesia 17 (65.4%) 0 (0%)
Mechanical allodynia 5 (19.2%) 0 (0%)
Muscle paresis 10 (38.5%) 0 (0%)
CMAP = compound muscle action potential; NRS = numeric rating scale; SD = standard deviationSchwenkreis et al. BMC Neuroscience 2010, 11:73
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tively on both sides in the neuralgia patients, i.e., from a
muscle supplied by the lesioned nerve (APB in median
nerve lesions, ADM in ulnar nerve lesions), and from a
muscle supplied by an unlesioned nerve (APB in ulnar
nerve lesions, ADM in median nerve lesions). Six patients
refused to participate in the whole experimental proce-
dure, therefore recordings were only obtained from the
muscle supplied by the lesioned nerve. In the osteoarthri-
tis patients as well as in the control group, recordings
were taken from the first dorsal interosseus (FDI) muscle.
Previous paired-pulse TMS studies had revealed compa-
rable results when recordings were obtained from differ-
ent small hand muscles, including APB, ADM and FDI
muscle [42,43]. The signals were recorded with a sam-
pling rate of 5 kHz, and amplified with a bandpass of 20
Hz-3 kHz, a sweep duration of 10-50 ms/div and a gain of
0.1-1 mV/div. They were stored on an EMG machine
(Neuropack 8, Nihon Kohden, Tokyo, Japan) for further
analysis. Motor threshold (MT) was determined at rest to
the nearest 1% of the stimulator output, and was defined
as the minimum intensity that produced five motor
evoked potentials >50 μV out of 10 trials [44]. The cor-
tico-cortical excitability (intracortical inhibition and
facilitation) was tested in the resting muscle by a paired-
pulse paradigm [45]. The second stimulus (test stimulus,
TS) was adjusted to evoke a motor evoked potential
(MEP) of approximately 1.0 mV, the conditioning stimu-
lus (CS) was set at 80% of the individual MT. MT, inten-
sity of CS and intensity of TS were individually adjusted
to each muscle in each patient. For paired-pulses, the
interstimulus intervals (ISI) 2, 4, 10, and 15 ms were cho-
sen. For each interval, at least eight responses were col-
lected. The paired pulses were mixed with a total number
of 32 suprathreshold single control stimuli, using the
same stimulation intensity as for the second (test) stimu-
lus. After the session, the amplitudes of all MEP
responses were manually measured, and mean MEP
amplitudes were calculated for each interstimulus inter-
val as well as for the control condition. Then for each
interstimulus interval the amplitude ratio of the mean
conditioned MEP to the mean control MEP was calcu-
lated. Parameters of intracortical inhibition (ICI) and of
intracortical facilitation (ICF) were defined as the aver-
ages of the MEP ratios obtained at inhibitory interstimu-
lus intervals of 2 and 4 ms, and at facilitatory intervals of
10 and 15 ms [46]. For all recordings, subjects were given
a u d i o - v i s u a l  f e e d b a c k  a t  h i g h  g a i n  t o  a s s i s t  c o m p l e t e
muscle relaxation. If EMG activity became apparent dur-
ing data collection, including a 10 ms pre-stimulus inter-
val, responses were rejected.
To control for a possible influence of TS intensity on
results of ICI and ICF, TS intensity (which had been
adjusted to achieve an unconditioned MEP of approxi-
mately 1 mV) relative to MT was calculated and com-
pared between groups.
Statistical analysis
To analyze excitability parameters, results obtained at the
neuralgia patients' affected side from the muscle supplied
by the lesioned nerve were considered separately from
results obtained from the muscle supplied by the unle-
sioned nerve. An ANOVA for repeated measurements
was calculated, with "side" (affected vs. unaffected) as
within-subjects factor, and "group" (neuralgia, osteoar-
thritis or control) as between-subjects factor, to analyze
the different parameters. In the control group, the left
hand was defined as the affected side, and the right hand
as the unaffected side for statistical purposes. Green-
house-Geisser procedure was used with epsilon-cor-
r e c t e d  d e g r e e s  o f  f r e e d o m ,  i f  d a t a  s h o w e d  s i g n i f i c a n t
deviations from sphericity. Paired and unpaired t-tests
were used for post-hoc analysis if the ANOVA revealed a
significant effect for one of the factors, or a significant
interaction between factors. Single-factorial ANOVA was
used to compare patients' age between groups, and
unpaired t-tests to compare current, mean and maximum
pain intensity as well as pain duration between neuralgia
and osteoarthritis patients. Unpaired t-tests were also
used to compare excitability parameters between sub-
groups of neuralgia patients with or without hypesthesia,
dysesthesia, mechanical allodynia or muscle paresis,
between neuralgia patients with lesions of the median or
ulnar nerve, and between neuralgia patients with moder-
ate/severe (NRS≥4) or mild (NRS<4) current pain inten-
sity. A paired t-test was used to compare MT determined
in both a muscle supplied by the lesioned nerve and a
muscle supplied by the unlesioned nerve in neuralgia
patients. Additionally, Cohen's d as an indicator of effect
size was calculated if t-tests yielded a significant p value.
Cohen's d is generally interpreted as follows: ≥1.0 very
large; ≥0.8 large; ≥0.5 moderate; 0.2-0.4 small [47].
Pearson's correlation coefficient was calculated in order
to detect a possible relationship between excitability
parameters and pain duration, as well as between excit-
ability parameters and the relative CMAP amplitude as a
parameter of peripheral nerve injury severity.
For all statistical tests, the SPSS 14.0 software package
(SPSS software, Munich, Germany) was used, and signifi-
cance was assumed at the 0.05 level.
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